Total Payments
$867,141
2024 Payments
$41,320
Companies
51
Transactions
3,784
Medicare Patients
55
Medicare Billing
$4,820
Payment Breakdown by Category
Other$625,594 (72.1%)
Travel$171,184 (19.7%)
Food & Beverage$60,370 (7.0%)
Consulting$9,560 (1.1%)
Education$433.29 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $625,594 | 343 | 72.1% |
| Travel and Lodging | $171,184 | 1,433 | 19.7% |
| Food and Beverage | $60,370 | 1,992 | 7.0% |
| Consulting Fee | $9,560 | 8 | 1.1% |
| Education | $433.29 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $500,744 | 2,511 | $0 (2020) |
| IDORSIA PHARMACEUTICALS US INC | $122,356 | 262 | $0 (2024) |
| Neos Therapeutics, LP | $99,012 | 160 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $91,339 | 203 | $0 (2024) |
| Pernix Therapeutics Holdings, Inc. | $29,053 | 115 | $0 (2019) |
| BioXcel Therapeutics, Inc. | $3,632 | 10 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $2,545 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,899 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,818 | 76 | $0 (2024) |
| Janssen Research & Development, LLC | $1,750 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41,320 | 160 | IDORSIA PHARMACEUTICALS US INC ($31,933) |
| 2023 | $76,071 | 256 | IDORSIA PHARMACEUTICALS US INC ($73,328) |
| 2022 | $107,711 | 299 | Teva Pharmaceuticals USA, Inc. ($87,610) |
| 2021 | $7,488 | 137 | Teva Pharmaceuticals USA, Inc. ($3,117) |
| 2020 | $28,888 | 174 | Allergan, Inc. ($25,178) |
| 2019 | $172,530 | 1,249 | Allergan Inc. ($171,495) |
| 2018 | $229,921 | 766 | Allergan Inc. ($159,524) |
| 2017 | $203,212 | 743 | Allergan Inc. ($144,547) |
All Payment Transactions
3,784 individual payment records from CMS Open Payments — Page 1 of 152
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $21.87 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/09/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,530.00 | General |
| Category: Insomnia | ||||||
| 12/09/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $58.96 | General |
| Category: Insomnia | ||||||
| 12/09/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $5.00 | General |
| Category: Insomnia | ||||||
| 12/05/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $118.11 | General |
| Category: Insomnia | ||||||
| 11/01/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: Insomnia | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,840.00 | General |
| 10/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | Cash or cash equivalent | $83.94 | General |
| Category: Insomnia | ||||||
| 10/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $51.17 | General |
| Category: Insomnia | ||||||
| 10/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $38.86 | General |
| Category: Insomnia | ||||||
| 10/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $35.00 | General |
| Category: Insomnia | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $18.02 | General |
| 10/28/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/28/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/25/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $378.98 | General |
| Category: Insomnia | ||||||
| 10/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.99 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Insomnia | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,530.00 | General |
| Category: Insomnia | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $155.00 | General |
| Category: Insomnia | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $75.35 | General |
| Category: Insomnia | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $58.96 | General |
| Category: Insomnia | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $55.00 | General |
| Category: Insomnia | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $38.86 | General |
| Category: Insomnia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 37 | 71 | $22,720 | $3,306 |
| 2022 | 1 | 18 | 29 | $9,280 | $1,514 |
Total Patients
55
Total Services
100
Medicare Billing
$4,820
Procedure Codes
3
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 56 | $17,920 | $1,836 | 10.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 15 | $4,800 | $1,470 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 29 | $9,280 | $1,514 | 16.3% |
About Dr. Gregg Friedman, MD
Dr. Gregg Friedman, MD is a Psychiatry healthcare provider based in Hallandale Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275531543.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregg Friedman, MD has received a total of $867,141 in payments from pharmaceutical and medical device companies, with $41,320 received in 2024. These payments were reported across 3,784 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($625,594).
As a Medicare-enrolled provider, Friedman has provided services to 55 Medicare beneficiaries, totaling 100 services with total Medicare billing of $4,820. Data is available for 2 years (2022–2023), covering 3 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Hallandale Beach, FL
- Active Since 07/12/2005
- Last Updated 06/26/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275531543
Products in Payments
- VRAYLAR (Drug) $403,700
- QUVIVIQ (Drug) $122,356
- Adzenys XR-ODT (Drug) $99,012
- NAMZARIC (Drug) $97,900
- AUSTEDO (Drug) $89,024
- SILENOR (Drug) $25,371
- ZOHYDRO ER (Drug) $3,656
- IGALMI (Drug) $3,632
- SPRAVATO (Drug) $2,216
- INVEGA SUSTENNA (Drug) $2,050
- HETLIOZ (Drug) $1,586
- Dayvigo (Drug) $1,530
- LOREEV XR (Drug) $1,081
- NUEDEXTA (Drug) $712.96
- REXULTI (Drug) $674.95
- ARISTADA (Drug) $635.09
- ADHANSIA XR (Drug) $453.60
- CAPLYTA (Drug) $442.03
- SECUADO (Drug) $407.45
- Austedo XR (Drug) $297.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.